Tropical Wave In Atlantic May Strengthen Into Storm, Poses Threat To US Coastlines
Merck Analysts Slash Their Forecasts After Q2 Results
Check Out What Whales Are Doing With UNH
UBS Maintains Buy on Merck & Co, Lowers Price Target to $142
Merck & Co Analyst Ratings
Procter & Gamble Analyst Ratings
A Closer Look at AbbVie's Options Market Dynamics
Analyzing Merck & Co In Comparison To Competitors In Pharmaceuticals Industry
Market Whales and Their Recent Bets on JPM Options
Insurance Giant Humana Stock Tumbles 9% After Q2 Earnings Beat, Issues Sub Par Profit Outlook
Favorite High-yield Dividend Stocks - BMO
J&J Wins Another FDA Label Expansion for Multiple Myeloma Therapy
Cerevel Therapeutics Ticks Higher Amid Nasdaq Delisting Notice for AbbVie Deal
Nasdaq Tumbles Amid Decline In Tech Stocks: Greed Index Moves To 'Fear' Zone
AMD Partners With Microsoft, Meta, And Google On New AI Accelerator Link Standard To Challenge Nvidia's Dominance
Consumer giants collectively performed poorly!
From Nestle to Procter & Gamble, and then to Starbucks, the entire consumer industry is showing signs of weakness, and the performance of consumer giants in the Chinese market is generally declining. As disposable income is constrained, consumers are increasingly focused on reducing consumption or turning to lower-priced commodities.
Another round of pre-announcement before the release! Will Japan raise interest rates and shrink its balance sheet at the same time? Technology stocks plummeted in response to the news overnight, and the Japanese yen rose.
NHK reports that the Bank of Japan is discussing raising interest rates to 0.25%, and combined with previous analyses, the central bank may propose specific measures to reduce the balance sheet at this meeting. Will this 'double whammy' affect global markets today?
Market Sells Off on Earnings Near Misses, FOMC Incoming | Wall Street Today
GSK Shingles Vaccine Cuts Dementia Risk
What's Going On With Exxon Mobil Shares Tuesday?